SlideShare a Scribd company logo
Ward Statistics
2012- 2013
2013 2012
Total admissions 2490 2364
Age Breakdown 2013 %age 2012 %age
0-1 month 274 11.2 263 11.6
I month- 1yr 830 34.7 642 27.1
1 yr- 5 yrs 746 34 922 39
>5yrs 640 23.5 536 22.6
OUTCOME
Discharged 2320 93.4 2164 91.5
DOR 120 3.8 96 4.7
LAMA 13 0.3 10 0.2
Expiry - - - -
Shifted to ICU 67 2.47 44 3.5
SYSTEM 2013 %age 2012 %age
Respiratory 472 22.1 446 19.5
GIT 460 20.7 378 16.2
Endocrinology 18 0.71 20 0.84
Urogenital 68 2.5 71 2.6
Infectious diseases 456 20 340 13.9
Metabolic disorders 140 5 124 4.8
CVS 10 0.35 8 0.3
SYSTEMIC BREAKDOWN
SYSTEM 2013 %age 2012 %age
CNS 398 13.1 297 12.7
CollagenVascular 07 0.28 06 0.26
Haem/Oncology 70 3.07 68 2.64
Poisoning 08 0.35 10 0.36
Neonatology 300 13.9 320 12.96
Dermatology 22 0.96 12 0.5
Surgery 310 12.71 324 13.6
SYSTEMIC BREAKDOWN
DIAGNOSIS 2013 %age 2012 %age
PNEUMONIA 398 13.1 297 12.7
•Bronchopneumonia 07 0.28 06 0.26
•Atypical Pneumonia 70 3.07 68 2.64
•Lobar Pneumonia 08 0.35 10 0.36
•Aspiration Pneumonia 300 13.9 320 12.96
Bronhiolitis 22 0.96 12 0.5
Bronchial asthma 310 12.71 324 13.6
RESPIRATORY SYSTEM 506
DIAGNOSIS 2013 %age 2012 %age
Croup 16 3.6 14 3.1
Otits media 6 1.2 4 0.9
Foreign body inhalation 4 0.7 2 0.3
Pleural effusion 6 12 3 0.6
Pharyngitis 04 0.7 - -
Tonsilliis 10 1.6 4 08
Cystic fibrosis 02 0.7 01 0.2
RESPIRATORY SYSTEM 506 vs 446
DIAGNOSIS 2013 %age 2012 %age
AWD 320 69.4 242 64
Bloody diarrhea 28 4.8 21 4.2
Chronic diarrhea 20 4.4 17 4.1
Celiac disease 4 0.85 8 2.1
Lactose intolerance 13 2.7 9 2.12
Post diarrheal distension 12 2.67 4 1.6
Gastritis 36 7 18 15
Pancreatitis 5 0.9 6 1
Gastrointestinal System 460 vs 378
DIAGNOSIS 2013 %age 2012 %age
GERD 34 8.5 29 8.9
Viral hepatitis 36 8.69 34 8.9
Hepatic enceph 2 0.43 3 0.5
CLD 2 0.43 02 0.5
AbdominalTB 4 0.86 2 1.05
Persistent diarrhea 6 1.3 10 2.4
Gastrointestinal System 460 vs 378
DIAGNOSIS 2013 %age 2012 %age
DKA 4 2.8 3 16.6
DM 5 28.5 6 28.7
Hypothyroidism 0 0 2 8.2
Short stature 2 14.2 4 16.6
CAH 4 16.6 2 8.2
Endocrine System 15 vs 17
DIAGNOSIS 2013 %age 2012 %age
Nephrotic synd 12 21 10 20
AGN 2 4.7 4 6.4
ARF 2 4.76 0 0
CRF 2 2.76 0 0
Congenital nephrosis 2 2.76 4 6.2
VUR 4 6.4 2 3.2
Posterior urethral valve 1 2 0 0
UTI 30 60 26 56
Urogenital System 55 vs 46
DIAGNOSIS 2013 %age 2012 %age
Enteric fever 158 34.4 120 39.4
Malaria 20 4.38 28 92
R sepsis 220 48.2 104 34.2
Pulm TB 14 3.01 8 2.6
Enteric Hep 2 0.43 8 2.6
PUO 8 1.75 18 5.9
Measles 35 7.6 8 2.6
Mumps 2 0.43 0 0
Infectious Diseases 456 vs 304
DIAGNOSIS 2013 %age 2012 %age
Chicken pox 2 0.43 0 0
Cholera 7 1.32 4 1.3
Septic arthritis 6 1 4 1.3
Rheumatic fever 2 0.4 1 0.7
Infectious Diseases 456 vs 304
DIAGNOSIS 2013 %age 2012 %age
Rickets 50 72 60 84.3
Storage diseases 02 2.2 01 1.6
RTA 02 2.2 0 0
Wilsons Disease 02 2.2 0 0
MPS 02 2.2 1 1.6
IEM 05 4.4 8 6.4
Metabolic Disorders 63 vs 70
DIAGNOSIS 2013 %age 2012 %age
VSD 2 20 4 36.3
PDA 4 40 4 36.3
Myocarditis 1 10 2 13
HTN 3 30 1 7
CVS 10 vs 11
DIAGNOSIS 2013 %age 2012 %age
Meningitis 110 26.9 82 29.7
TBM 10 3.35 14 4.9
Hydrocephalus 08 3 10 3.5
Encephalitis 32 107 20 7.09
Febrile fits 102 34.2 94 33.3
Epilepsy 18 6.04 24 5.6
GBS 04 1.34 02 0.7
Cerebral palsy 14 4.69 16 5.6
CNS 298 vs 282
DIAGNOSIS 2013 %age 2012 %age
Subdural hematoma 04 4.69 16 5.6
Brain tumours 3 4 2 0.7
CNS 298 vs 282
DIAGNOSIS 2013 %age 2012 %age
SLE 04 50 02 13
JRA 02 25 03 50
HSP 02 25 01 12
COLLAGENVASCULAR DIS 08VS 06
DIAGNOSIS 2013 %age 2012 %age
Thalessemia 06 8.57 04 6.06
ITP 11 14.5 12 15.5
Hemolytic anemia 01 1.4 04 6.06
Ro G6PD 04 5.7 01 2
Iron defeciency 52 74 47 22
Megaloblastic anemia 02 3 0 0
Fanconis Anemia 00 00 02 2.08
HAEMATOLOGY ONCOLOGY 70VS 66
DIAGNOSIS 2013 %age 2012 %age
ALL 06 8.5 02 8.22
Lymphoma 02 2.8 02 8.22
Wilms tumour 02 2.8 00 00
Aplastic anemia 10 14.57 07 4
HAEMATOLOGY ONCOLOGY 70VS 66
DIAGNOSIS 2013 %age 2012 %age
Aspirin poisoning - - 2 20
Paracetamol poisoning 3 40 3 30
Kerosene oil poisoning 2 25 1 10
Mortein poisoning 2 25 3 30
Bleach - - 1 10
Ativan poisoning 1 10 - -
POISONING 8 vs 10
DIAGNOSIS 2013 %age 2012 %age
Sepsis 142 47 152 47.5
JNN 96 32 110 34
Asphyxia 06 2.1 10 3.12
Prematurity 4.3 12 3.7 3.7
Septic arthritis 2 1.33 00 00
Congenital Hypthyr 01 0.19 00 00
NEONATOLOGY 300 VS 320
DIAGNOSIS 2013 %age 2012 %age
Sepsis 142 47 152 47.5
JNN 96 32 110 34
Asphyxia 06 2.1 10 3.12
Prematurity 4.3 12 3.7 3.7
Septic arthritis 2 1.33 00 00
Congenital Hypthyr 01 0.19 00 00
NEONATOLOGY 300 VS 320
DIAGNOSIS 2013 %age 2012 %age
PLASTIC SURGERY 20 6.45 16 4.9
Cleft lip 4 1.29 4 1.2
Cleft palate 4 1.29 6 1.85
Hypospadias 12 3.87 6 1.85
NEUROSURGERY 56 18.06 60 17.2
Meningomyelocele 10 3.22 6 1.85
Head injury 22 7.09 28 7.4
Hydrocephalus 18 5.8 22 6.8
SOL 6 1.93 4 1.2
SURGERY 310 vs 324
DIAGNOSIS 2013 %age 2012 %age
Ac Appendicitis 50 25.5 60 18.5
Hirschsprung disease 16 3.11 2 0.6
Intestinal obstruction 30 8.21 4 1.2
Inguinal Hernia 26 15.22 20 6.1
Bleeding P/R 8 5.31 20 6.1
Undescended testes 16 4.21 16 4.9
Rectal polyp 8 8.21 24 7.4
Hydrocele 8 4.21 14 4.3
PAEDS SURGERY 196 vs 236
DIAGNOSIS 2013 %age 2012 %age
Intussusception 6 3.11 4 1.2
Circumcision 10 13.11 08 2.1
Colostomy 6 3.1 6 1.85
Testicular torsion - - 2 0.6
ORTHOPEDICS 38 12.25 16 4.92
Fracture femur 12 31.5 8 2.4
Fracture Humerus 4 10.5 10 3
Fracture Tibia 6 15.76 6 1.85
PAEDS SURGERY 196 vs 236
DIAGNOSIS 2013 %age 2012 %age
DDH 2 5.26 - -
Telepes Equinovarus 10 26.5 8 2.4
DIAGNOSIS 2013 %age 2012 %age
2m – 2 yrs 1630 62 824 54
No malnutrition 630 61 500 60
1st degree 302 29.5 240 29
2nd degree 76 7.43 68 8.2
3rd degree 14 1.36 6 1.9
2 yrs- 5 yrs 608 37.3 690 45.4
No malnutrition 430 70.7 548 79.4
1st degree 110 18.09 92 13.3
2nd degree 62 10.01 40 5.7
3rd degree 6 0.98 10 1.4
MALNUTRITION DATA 1630VS 1514

More Related Content

What's hot

Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyueda2015
 
Managing CV risk in Inflammatory Arthritis (Focusing on Gout)
Managing CV risk in Inflammatory Arthritis (Focusing on Gout)Managing CV risk in Inflammatory Arthritis (Focusing on Gout)
Managing CV risk in Inflammatory Arthritis (Focusing on Gout)
Sidney Erwin Manahan
 
ueda2012 metabolic memory-d.mgahed
ueda2012 metabolic memory-d.mgahedueda2012 metabolic memory-d.mgahed
ueda2012 metabolic memory-d.mgahed
ueda2015
 
Management of diabetes in heart disease
Management of diabetes  in heart diseaseManagement of diabetes  in heart disease
Management of diabetes in heart diseaseGopi Krishna Rayidi
 
Esc np leader oral abs 86477 v13.0 2017 08-25
Esc np leader oral abs 86477 v13.0 2017 08-25Esc np leader oral abs 86477 v13.0 2017 08-25
Esc np leader oral abs 86477 v13.0 2017 08-25
SoM
 
Men and long-term health conditions
Men and long-term health conditionsMen and long-term health conditions
Men and long-term health conditions
Men's Health Forum
 
NbaPythagoreanTest pdf
NbaPythagoreanTest pdfNbaPythagoreanTest pdf
NbaPythagoreanTest pdf
Kevin Cottington
 
AUREL TOMA - Impact of Multivessel Versus Single-Vessel Disease on Outcomes A...
AUREL TOMA - Impact of Multivessel Versus Single-Vessel Disease on Outcomes A...AUREL TOMA - Impact of Multivessel Versus Single-Vessel Disease on Outcomes A...
AUREL TOMA - Impact of Multivessel Versus Single-Vessel Disease on Outcomes A...
Euro CTO Club
 
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
KouameK
 
Signal prioritisation and serious medical events
Signal prioritisation and serious medical eventsSignal prioritisation and serious medical events
Signal prioritisation and serious medical events
Francois MAIGNEN
 
Care of patients with diabetic kidney disease
Care of patients with diabetic kidney diseaseCare of patients with diabetic kidney disease
Care of patients with diabetic kidney disease
JimRitchie14
 
Epidemiological analysis of measles outbreak
Epidemiological analysis of measles outbreakEpidemiological analysis of measles outbreak
Epidemiological analysis of measles outbreak
Dr. Amit Bhalchandra Bhavsar
 
高雄醫師會誌96期-醫政廣場~林俊傑、王欽程、許弘毅-基層醫療之現況與未來發展
高雄醫師會誌96期-醫政廣場~林俊傑、王欽程、許弘毅-基層醫療之現況與未來發展高雄醫師會誌96期-醫政廣場~林俊傑、王欽程、許弘毅-基層醫療之現況與未來發展
高雄醫師會誌96期-醫政廣場~林俊傑、王欽程、許弘毅-基層醫療之現況與未來發展
Ks doctor
 

What's hot (18)

Ueda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toonyUeda2015 diabetes control dr.lobna el-toony
Ueda2015 diabetes control dr.lobna el-toony
 
Managing CV risk in Inflammatory Arthritis (Focusing on Gout)
Managing CV risk in Inflammatory Arthritis (Focusing on Gout)Managing CV risk in Inflammatory Arthritis (Focusing on Gout)
Managing CV risk in Inflammatory Arthritis (Focusing on Gout)
 
ueda2012 metabolic memory-d.mgahed
ueda2012 metabolic memory-d.mgahedueda2012 metabolic memory-d.mgahed
ueda2012 metabolic memory-d.mgahed
 
Forensic Medicine Audit 2013
Forensic Medicine Audit 2013Forensic Medicine Audit 2013
Forensic Medicine Audit 2013
 
TNCS audit 2016
TNCS audit 2016TNCS audit 2016
TNCS audit 2016
 
Management of diabetes in heart disease
Management of diabetes  in heart diseaseManagement of diabetes  in heart disease
Management of diabetes in heart disease
 
Esc np leader oral abs 86477 v13.0 2017 08-25
Esc np leader oral abs 86477 v13.0 2017 08-25Esc np leader oral abs 86477 v13.0 2017 08-25
Esc np leader oral abs 86477 v13.0 2017 08-25
 
Men and long-term health conditions
Men and long-term health conditionsMen and long-term health conditions
Men and long-term health conditions
 
NbaPythagoreanTest pdf
NbaPythagoreanTest pdfNbaPythagoreanTest pdf
NbaPythagoreanTest pdf
 
AUREL TOMA - Impact of Multivessel Versus Single-Vessel Disease on Outcomes A...
AUREL TOMA - Impact of Multivessel Versus Single-Vessel Disease on Outcomes A...AUREL TOMA - Impact of Multivessel Versus Single-Vessel Disease on Outcomes A...
AUREL TOMA - Impact of Multivessel Versus Single-Vessel Disease on Outcomes A...
 
Kdigo 2012 ckd_gl
Kdigo 2012 ckd_glKdigo 2012 ckd_gl
Kdigo 2012 ckd_gl
 
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
Rotarians and Diabetes Prevention Developing Healthy Communities: Part 1 rag ...
 
Signal prioritisation and serious medical events
Signal prioritisation and serious medical eventsSignal prioritisation and serious medical events
Signal prioritisation and serious medical events
 
Care of patients with diabetic kidney disease
Care of patients with diabetic kidney diseaseCare of patients with diabetic kidney disease
Care of patients with diabetic kidney disease
 
Strive Teleconf Presentation Oct11 2006
Strive Teleconf Presentation Oct11 2006Strive Teleconf Presentation Oct11 2006
Strive Teleconf Presentation Oct11 2006
 
Epidemiological analysis of measles outbreak
Epidemiological analysis of measles outbreakEpidemiological analysis of measles outbreak
Epidemiological analysis of measles outbreak
 
高雄醫師會誌96期-醫政廣場~林俊傑、王欽程、許弘毅-基層醫療之現況與未來發展
高雄醫師會誌96期-醫政廣場~林俊傑、王欽程、許弘毅-基層醫療之現況與未來發展高雄醫師會誌96期-醫政廣場~林俊傑、王欽程、許弘毅-基層醫療之現況與未來發展
高雄醫師會誌96期-醫政廣場~林俊傑、王欽程、許弘毅-基層醫療之現況與未來發展
 
1. Julia Critchley, St. George's, University of London, United Kingdom
1. Julia Critchley, St. George's, University of London, United Kingdom1. Julia Critchley, St. George's, University of London, United Kingdom
1. Julia Critchley, St. George's, University of London, United Kingdom
 

Similar to Ward statistics 2012 2013

Globocan 2020 Viet Nam.pdf
Globocan 2020 Viet Nam.pdfGlobocan 2020 Viet Nam.pdf
Globocan 2020 Viet Nam.pdf
John Nguyen
 
CKD Epidemiology 2014
CKD Epidemiology 2014CKD Epidemiology 2014
CKD Epidemiology 2014
Meguid Nahas
 
Radiographic Decision Making
Radiographic Decision MakingRadiographic Decision Making
Radiographic Decision Making
Kristopher Maday
 
Indicadores cq-ene-jun-2012-2013-hnaaa
Indicadores cq-ene-jun-2012-2013-hnaaaIndicadores cq-ene-jun-2012-2013-hnaaa
Indicadores cq-ene-jun-2012-2013-hnaaa
Hospital Nacional Almanzor Aguinaga Asenjo
 
Kshivets astana wscts2017
Kshivets astana wscts2017Kshivets astana wscts2017
Kshivets astana wscts2017
Oleg Kshivets
 
The Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney DiseaseThe Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney DiseaseJoel Topf
 
Final mor.mangsir
Final mor.mangsirFinal mor.mangsir
Final mor.mangsirManoj Yadav
 
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...
appfromlab
 
Scleroderma in children and young people
Scleroderma in children and young peopleScleroderma in children and young people
Scleroderma in children and young people
Scleroderma & Raynaud's UK (SRUK)
 
Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity MedicationsCardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
Christos Argyropoulos
 
the advance on Strategy to optimally achieve blood glucose control
the advance on Strategy to optimally achieve blood glucose controlthe advance on Strategy to optimally achieve blood glucose control
the advance on Strategy to optimally achieve blood glucose control
januar arifin
 
O&g sgh updates focus on contraception
O&g sgh updates  focus on contraception O&g sgh updates  focus on contraception
O&g sgh updates focus on contraception chaimingcheng
 
AHS13 Peter Polack — The Role of Diet in Dry Eye Disease
AHS13 Peter Polack — The Role of Diet in Dry Eye Disease AHS13 Peter Polack — The Role of Diet in Dry Eye Disease
AHS13 Peter Polack — The Role of Diet in Dry Eye Disease
Ancestral Health Society
 
Computerized scan findings and their correlation with outcome in patients wit...
Computerized scan findings and their correlation with outcome in patients wit...Computerized scan findings and their correlation with outcome in patients wit...
Computerized scan findings and their correlation with outcome in patients wit...
Amit Agrawal
 
ueda2012 glycemic control cvd debate f-d.khalifa
ueda2012 glycemic control cvd debate f-d.khalifaueda2012 glycemic control cvd debate f-d.khalifa
ueda2012 glycemic control cvd debate f-d.khalifa
ueda2015
 
3 forette prevention of alzheimer ifa 2012] 2
3 forette prevention of alzheimer  ifa 2012] 23 forette prevention of alzheimer  ifa 2012] 2
3 forette prevention of alzheimer ifa 2012] 2ifa2012
 
Diabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slidesDiabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slides
Christos Argyropoulos
 
Status of disease in the state number 4 on the basis of epidemiological stud...
Status of disease in the state number 4 on the basis of  epidemiological stud...Status of disease in the state number 4 on the basis of  epidemiological stud...
Status of disease in the state number 4 on the basis of epidemiological stud...
krishnaacharya22
 

Similar to Ward statistics 2012 2013 (20)

Yearly er stats
Yearly er statsYearly er stats
Yearly er stats
 
Globocan 2020 Viet Nam.pdf
Globocan 2020 Viet Nam.pdfGlobocan 2020 Viet Nam.pdf
Globocan 2020 Viet Nam.pdf
 
CKD Epidemiology 2014
CKD Epidemiology 2014CKD Epidemiology 2014
CKD Epidemiology 2014
 
Radiographic Decision Making
Radiographic Decision MakingRadiographic Decision Making
Radiographic Decision Making
 
Indicadores cq-ene-jun-2012-2013-hnaaa
Indicadores cq-ene-jun-2012-2013-hnaaaIndicadores cq-ene-jun-2012-2013-hnaaa
Indicadores cq-ene-jun-2012-2013-hnaaa
 
Kshivets astana wscts2017
Kshivets astana wscts2017Kshivets astana wscts2017
Kshivets astana wscts2017
 
The Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney DiseaseThe Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney Disease
 
NSAIDs ASA GI protection
NSAIDs ASA GI protectionNSAIDs ASA GI protection
NSAIDs ASA GI protection
 
Final mor.mangsir
Final mor.mangsirFinal mor.mangsir
Final mor.mangsir
 
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...
NSM-NCD2013 Symposium 1 - Non-communicable Diseases in Asean - Current Situat...
 
Scleroderma in children and young people
Scleroderma in children and young peopleScleroderma in children and young people
Scleroderma in children and young people
 
Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity MedicationsCardiometabolic Benefits of Renal Diabetes and Obesity Medications
Cardiometabolic Benefits of Renal Diabetes and Obesity Medications
 
the advance on Strategy to optimally achieve blood glucose control
the advance on Strategy to optimally achieve blood glucose controlthe advance on Strategy to optimally achieve blood glucose control
the advance on Strategy to optimally achieve blood glucose control
 
O&g sgh updates focus on contraception
O&g sgh updates  focus on contraception O&g sgh updates  focus on contraception
O&g sgh updates focus on contraception
 
AHS13 Peter Polack — The Role of Diet in Dry Eye Disease
AHS13 Peter Polack — The Role of Diet in Dry Eye Disease AHS13 Peter Polack — The Role of Diet in Dry Eye Disease
AHS13 Peter Polack — The Role of Diet in Dry Eye Disease
 
Computerized scan findings and their correlation with outcome in patients wit...
Computerized scan findings and their correlation with outcome in patients wit...Computerized scan findings and their correlation with outcome in patients wit...
Computerized scan findings and their correlation with outcome in patients wit...
 
ueda2012 glycemic control cvd debate f-d.khalifa
ueda2012 glycemic control cvd debate f-d.khalifaueda2012 glycemic control cvd debate f-d.khalifa
ueda2012 glycemic control cvd debate f-d.khalifa
 
3 forette prevention of alzheimer ifa 2012] 2
3 forette prevention of alzheimer  ifa 2012] 23 forette prevention of alzheimer  ifa 2012] 2
3 forette prevention of alzheimer ifa 2012] 2
 
Diabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slidesDiabetic kidney disease 2021 all_slides
Diabetic kidney disease 2021 all_slides
 
Status of disease in the state number 4 on the basis of epidemiological stud...
Status of disease in the state number 4 on the basis of  epidemiological stud...Status of disease in the state number 4 on the basis of  epidemiological stud...
Status of disease in the state number 4 on the basis of epidemiological stud...
 

Ward statistics 2012 2013

  • 3. Age Breakdown 2013 %age 2012 %age 0-1 month 274 11.2 263 11.6 I month- 1yr 830 34.7 642 27.1 1 yr- 5 yrs 746 34 922 39 >5yrs 640 23.5 536 22.6 OUTCOME Discharged 2320 93.4 2164 91.5 DOR 120 3.8 96 4.7 LAMA 13 0.3 10 0.2 Expiry - - - - Shifted to ICU 67 2.47 44 3.5
  • 4. SYSTEM 2013 %age 2012 %age Respiratory 472 22.1 446 19.5 GIT 460 20.7 378 16.2 Endocrinology 18 0.71 20 0.84 Urogenital 68 2.5 71 2.6 Infectious diseases 456 20 340 13.9 Metabolic disorders 140 5 124 4.8 CVS 10 0.35 8 0.3 SYSTEMIC BREAKDOWN
  • 5. SYSTEM 2013 %age 2012 %age CNS 398 13.1 297 12.7 CollagenVascular 07 0.28 06 0.26 Haem/Oncology 70 3.07 68 2.64 Poisoning 08 0.35 10 0.36 Neonatology 300 13.9 320 12.96 Dermatology 22 0.96 12 0.5 Surgery 310 12.71 324 13.6 SYSTEMIC BREAKDOWN
  • 6. DIAGNOSIS 2013 %age 2012 %age PNEUMONIA 398 13.1 297 12.7 •Bronchopneumonia 07 0.28 06 0.26 •Atypical Pneumonia 70 3.07 68 2.64 •Lobar Pneumonia 08 0.35 10 0.36 •Aspiration Pneumonia 300 13.9 320 12.96 Bronhiolitis 22 0.96 12 0.5 Bronchial asthma 310 12.71 324 13.6 RESPIRATORY SYSTEM 506
  • 7. DIAGNOSIS 2013 %age 2012 %age Croup 16 3.6 14 3.1 Otits media 6 1.2 4 0.9 Foreign body inhalation 4 0.7 2 0.3 Pleural effusion 6 12 3 0.6 Pharyngitis 04 0.7 - - Tonsilliis 10 1.6 4 08 Cystic fibrosis 02 0.7 01 0.2 RESPIRATORY SYSTEM 506 vs 446
  • 8. DIAGNOSIS 2013 %age 2012 %age AWD 320 69.4 242 64 Bloody diarrhea 28 4.8 21 4.2 Chronic diarrhea 20 4.4 17 4.1 Celiac disease 4 0.85 8 2.1 Lactose intolerance 13 2.7 9 2.12 Post diarrheal distension 12 2.67 4 1.6 Gastritis 36 7 18 15 Pancreatitis 5 0.9 6 1 Gastrointestinal System 460 vs 378
  • 9. DIAGNOSIS 2013 %age 2012 %age GERD 34 8.5 29 8.9 Viral hepatitis 36 8.69 34 8.9 Hepatic enceph 2 0.43 3 0.5 CLD 2 0.43 02 0.5 AbdominalTB 4 0.86 2 1.05 Persistent diarrhea 6 1.3 10 2.4 Gastrointestinal System 460 vs 378
  • 10. DIAGNOSIS 2013 %age 2012 %age DKA 4 2.8 3 16.6 DM 5 28.5 6 28.7 Hypothyroidism 0 0 2 8.2 Short stature 2 14.2 4 16.6 CAH 4 16.6 2 8.2 Endocrine System 15 vs 17
  • 11. DIAGNOSIS 2013 %age 2012 %age Nephrotic synd 12 21 10 20 AGN 2 4.7 4 6.4 ARF 2 4.76 0 0 CRF 2 2.76 0 0 Congenital nephrosis 2 2.76 4 6.2 VUR 4 6.4 2 3.2 Posterior urethral valve 1 2 0 0 UTI 30 60 26 56 Urogenital System 55 vs 46
  • 12. DIAGNOSIS 2013 %age 2012 %age Enteric fever 158 34.4 120 39.4 Malaria 20 4.38 28 92 R sepsis 220 48.2 104 34.2 Pulm TB 14 3.01 8 2.6 Enteric Hep 2 0.43 8 2.6 PUO 8 1.75 18 5.9 Measles 35 7.6 8 2.6 Mumps 2 0.43 0 0 Infectious Diseases 456 vs 304
  • 13. DIAGNOSIS 2013 %age 2012 %age Chicken pox 2 0.43 0 0 Cholera 7 1.32 4 1.3 Septic arthritis 6 1 4 1.3 Rheumatic fever 2 0.4 1 0.7 Infectious Diseases 456 vs 304
  • 14. DIAGNOSIS 2013 %age 2012 %age Rickets 50 72 60 84.3 Storage diseases 02 2.2 01 1.6 RTA 02 2.2 0 0 Wilsons Disease 02 2.2 0 0 MPS 02 2.2 1 1.6 IEM 05 4.4 8 6.4 Metabolic Disorders 63 vs 70
  • 15. DIAGNOSIS 2013 %age 2012 %age VSD 2 20 4 36.3 PDA 4 40 4 36.3 Myocarditis 1 10 2 13 HTN 3 30 1 7 CVS 10 vs 11
  • 16. DIAGNOSIS 2013 %age 2012 %age Meningitis 110 26.9 82 29.7 TBM 10 3.35 14 4.9 Hydrocephalus 08 3 10 3.5 Encephalitis 32 107 20 7.09 Febrile fits 102 34.2 94 33.3 Epilepsy 18 6.04 24 5.6 GBS 04 1.34 02 0.7 Cerebral palsy 14 4.69 16 5.6 CNS 298 vs 282
  • 17. DIAGNOSIS 2013 %age 2012 %age Subdural hematoma 04 4.69 16 5.6 Brain tumours 3 4 2 0.7 CNS 298 vs 282
  • 18. DIAGNOSIS 2013 %age 2012 %age SLE 04 50 02 13 JRA 02 25 03 50 HSP 02 25 01 12 COLLAGENVASCULAR DIS 08VS 06
  • 19. DIAGNOSIS 2013 %age 2012 %age Thalessemia 06 8.57 04 6.06 ITP 11 14.5 12 15.5 Hemolytic anemia 01 1.4 04 6.06 Ro G6PD 04 5.7 01 2 Iron defeciency 52 74 47 22 Megaloblastic anemia 02 3 0 0 Fanconis Anemia 00 00 02 2.08 HAEMATOLOGY ONCOLOGY 70VS 66
  • 20. DIAGNOSIS 2013 %age 2012 %age ALL 06 8.5 02 8.22 Lymphoma 02 2.8 02 8.22 Wilms tumour 02 2.8 00 00 Aplastic anemia 10 14.57 07 4 HAEMATOLOGY ONCOLOGY 70VS 66
  • 21. DIAGNOSIS 2013 %age 2012 %age Aspirin poisoning - - 2 20 Paracetamol poisoning 3 40 3 30 Kerosene oil poisoning 2 25 1 10 Mortein poisoning 2 25 3 30 Bleach - - 1 10 Ativan poisoning 1 10 - - POISONING 8 vs 10
  • 22. DIAGNOSIS 2013 %age 2012 %age Sepsis 142 47 152 47.5 JNN 96 32 110 34 Asphyxia 06 2.1 10 3.12 Prematurity 4.3 12 3.7 3.7 Septic arthritis 2 1.33 00 00 Congenital Hypthyr 01 0.19 00 00 NEONATOLOGY 300 VS 320
  • 23. DIAGNOSIS 2013 %age 2012 %age Sepsis 142 47 152 47.5 JNN 96 32 110 34 Asphyxia 06 2.1 10 3.12 Prematurity 4.3 12 3.7 3.7 Septic arthritis 2 1.33 00 00 Congenital Hypthyr 01 0.19 00 00 NEONATOLOGY 300 VS 320
  • 24. DIAGNOSIS 2013 %age 2012 %age PLASTIC SURGERY 20 6.45 16 4.9 Cleft lip 4 1.29 4 1.2 Cleft palate 4 1.29 6 1.85 Hypospadias 12 3.87 6 1.85 NEUROSURGERY 56 18.06 60 17.2 Meningomyelocele 10 3.22 6 1.85 Head injury 22 7.09 28 7.4 Hydrocephalus 18 5.8 22 6.8 SOL 6 1.93 4 1.2 SURGERY 310 vs 324
  • 25. DIAGNOSIS 2013 %age 2012 %age Ac Appendicitis 50 25.5 60 18.5 Hirschsprung disease 16 3.11 2 0.6 Intestinal obstruction 30 8.21 4 1.2 Inguinal Hernia 26 15.22 20 6.1 Bleeding P/R 8 5.31 20 6.1 Undescended testes 16 4.21 16 4.9 Rectal polyp 8 8.21 24 7.4 Hydrocele 8 4.21 14 4.3 PAEDS SURGERY 196 vs 236
  • 26. DIAGNOSIS 2013 %age 2012 %age Intussusception 6 3.11 4 1.2 Circumcision 10 13.11 08 2.1 Colostomy 6 3.1 6 1.85 Testicular torsion - - 2 0.6 ORTHOPEDICS 38 12.25 16 4.92 Fracture femur 12 31.5 8 2.4 Fracture Humerus 4 10.5 10 3 Fracture Tibia 6 15.76 6 1.85 PAEDS SURGERY 196 vs 236
  • 27. DIAGNOSIS 2013 %age 2012 %age DDH 2 5.26 - - Telepes Equinovarus 10 26.5 8 2.4
  • 28. DIAGNOSIS 2013 %age 2012 %age 2m – 2 yrs 1630 62 824 54 No malnutrition 630 61 500 60 1st degree 302 29.5 240 29 2nd degree 76 7.43 68 8.2 3rd degree 14 1.36 6 1.9 2 yrs- 5 yrs 608 37.3 690 45.4 No malnutrition 430 70.7 548 79.4 1st degree 110 18.09 92 13.3 2nd degree 62 10.01 40 5.7 3rd degree 6 0.98 10 1.4 MALNUTRITION DATA 1630VS 1514